Traders should base analysis on the underlying index (XBI), as LABU's price action is distorted by leverage-induced drift.

First, the Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU) seeks daily investment results, before fees and expenses, of 300% of the performance of the aforementioned biotech index. Second, the ...

Thanks to some favorable news from the Food and Drug Administration (FDA) and more mergers and acquisitions activity, biotechnology stocks and exchange traded are shaking off their previously ...

Seeking Alpha Quant rates LABU as a strong Sell, but I rates it as a Buy due to bullish market conditions. LABU is a leveraged ETF that seeks to track 3x the daily performance of the S&P Biotechnology ...

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have ...

Sean Ross is a strategic adviser at 1031x.com, Investopedia contributor, and the founder and manager of Free Lances Ltd. The Direxion Daily S&P Biotech Bull 3X Fund (NYSEARCA: LABU) is an exchange ...

Steven Nickolas is a writer and has 10+ years of experience working as a consultant to retail and institutional investors. Suzanne is a content marketer, writer, and fact-checker. She holds a Bachelor ...

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, ...

Over the past 12 months, LABU has changed by 53.48%, with its 52-week range spanning from 32.55 to 176.44. What Is the Daily Trading Range for LABU? The daily trading range for LABU has fluctuated ...

"You're kind of dumb if you don't do something with pumpkin in the fall," Joaquín Simó says very matter of factly at his Alphabet City cocktail bar, Pouring Ribbons. "It's like not doing hot drinks in ...

The Direxion Daily S&P Biotech Bull 3X Fund (NYSEARCA: LABU) is an exchange traded fund (ETF) that seeks to replicate 300% of the daily performance (before fees and expenses) of its underlying index, ...